Attovia Therapeutics, Inc. Common Stock (ATTO) — Working Capital to Net Assets Ratio
Attovia Therapeutics, Inc. Common Stock (ATTO) has a Working Capital to Net Assets ratio of 93.8% as of June 2026. Working capital of $105.79 Million (current assets of $118.40 Million minus current liabilities of $12.62 Million) is measured against net assets of $112.77 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of Attovia Therapeutics, Inc. Common Stock to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Attovia Therapeutics, Inc. Common Stock Working Capital to Net Assets (2024–2025)
This chart shows how Attovia Therapeutics, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 93.8%, reflecting working capital of $105.79 Million against net assets of $112.77 Million USD. For the complete balance sheet picture, see Attovia Therapeutics, Inc. Common Stock balance sheet assets.
Annual Working Capital to Net Assets for Attovia Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Attovia Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check ATTO asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.4% | $145.29 Million | $150.79 Million | $156.29 Million | $11.01 Million | ▼ -7.9 pp |
| 2024 | 104.2% | $64.76 Million | $62.13 Million | $72.48 Million | $7.72 Million | — |